According to reports, the world's biggest banks need to boost their capital by 115 billion Euros ($155 billion). This is required so that the banks are able to comply with tougher rules.
More than 60% of the shortfall is in Europe, where the lenders have been slower to strengthen.
The capital shortfall fell by _83 billion during the second half of last year, as banks retained more of their profits and raised capital, although the pace of improvement was not as quick in Europe as elsewhere.
However, the lenders have made progress in increasing the capital effectively.
The Basel Committee of global regulators on Wednesday said the shortfall at top international banks was based on a target to hold a minimum core capital level of 7 %, plus capital surcharges required for the 28 biggest banks.
The findings of the committee were based on their balance sheet at the end of the last year.
Until 2019, the new capital rules do not fully come into effect. The experts and the analysts expect the banks to recover the shortfall.
According to the experts, the banks should strengthen themselves by using their profits and not by issuing more shares.
There are a lot of things not going right at the IRS and mostly so when it comes to filing for Earned Income Tax Credits (EITC).
In December 2014, a report by Watchdog.org showed that that an audit by the IRS documented twenty four percent...
A new study by the Massachusetts Institute of Technology (MIT) has revealed that Istanbul lies...
The Michael J Fox Foundation is aiming to test wearable sensors in smart watches made by Intel's...
There was a time just a few years back when Spain ranked second after Greece, as a figure of the euro zone's huge debt crisis and economic slowdown. The country's unemployment climbed to a huge twenty seven percent and the economy was still...
In January, trade surplus of Germany decreased since plunge in imports was more than a drop in...
On Tuesday, tech giant Google released latest to show how much of its online traffic is...
German drugmaker Merck said that its experimental cancer medicine evofosfamidehas failed in the last stage of clinical tests due to which it won't seek regulatory approval for its treatment.
On Monday, Darmstadt, Germany-based Merck said...
On Thursday, the US Federal Bureau of Investigation (FBI...
In an announcement made via a blog post on Thursday,...
In a blog post published on Wednesday, Twitter-owned...
A draft New York legislation proposes the use of a...
© 2011 AustrianTribune - Tribune Online Services. All times CET (GMT + 1.00).